Back to News
Market Impact: 0.3

SOPHiA GENETICS SA Reports Third Quarter 2026 Financial Results

Source: Nasdaq

Corporate EarningsHealthcare & BiotechCompany Fundamentals

SOPHiA GENETICS reported Q3 2026 revenue of $24.3 million, up 25% year over year. Net loss increased 1% to $20.3 million, while Adjusted EBITDA loss improved 31% to $6.1 million.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.25

Ticker Sentiment

SOPH0.45

More News

From AllMind Research

Browse all research